About N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide
N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide (PubChem CID 91902581) has the molecular formula C22H34N2O5
and a molecular weight of 406.52 g/mol. Its IUPAC name is N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide.
Analyze N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide?
The IUPAC name of N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide (CID 91902581) is N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide.
What is the SMILES notation for N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide?
The canonical SMILES for N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide is COc1cc(C(=O)N(CCCC(=O)NC2CCCC2)C(C)C)cc(OC)c1OC.
What is the InChIKey of N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide?
The InChIKey is JJRGOLBIAWGAPH-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H34N2O5/c1-15(2)24(12-8-11-20(25)23-17-9-6-7-10-17)22(26)16-13-18(27-3)21(29-5)19(14-16)28-4/h13-15,17H,6-12H2,1-5H3,(H,23,25).
What are the key properties of N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide?
N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide has a molecular weight of 406.52 g/mol, XLogP of 3.40, 10 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(cyclopentylamino)-4-oxobutyl]-3,4,5-trimethoxy-N-propan-2-ylbenzamide is sourced from PubChem (CID 91902581), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).